{"id":7510,"date":"2024-08-28T10:18:33","date_gmt":"2024-08-28T15:18:33","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=7510"},"modified":"2024-08-28T10:18:37","modified_gmt":"2024-08-28T15:18:37","slug":"fda-could-soon-limit-use-of-only-drug-for-covid-prevention","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2024\/08\/28\/fda-could-soon-limit-use-of-only-drug-for-covid-prevention\/","title":{"rendered":"FDA Could Soon Limit Use of Only Drug for COVID Prevention"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p><a href=\"https:\/\/www.medpagetoday.com\/infectiousdisease\/covid19\/111681?xid=nl_mpt_morningbreak2024-08-28&amp;mh=07f73d99b2b546c079b0b5a2312d87b1&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=MorningBreak_082824&amp;utm_term=NL_Gen_Int_Daily_News_Update_active\">MedPageToday<\/a> Pemivibart may have reduced activity against growing variant KP.3.1.1, agency warns. Pemivibart (Pemgarda) should only be used for pre-exposure prophylaxis of COVID-19 in immunocompromised patients when the combined national frequency of SARS-CoV-2 variants with substantially reduced susceptibility to the drug is less than or equal to 90%, the FDA announced on Monday.<\/p>\n\n\n\n<p>The agency revised the emergency use authorization (EUA) for the long-acting monoclonal antibody based on available information about SARS-CoV-2 variant susceptibility to pemivibart and national variant frequency, Patrizia Cavazzoni, MD, director of the FDA&#8217;s Center for Drug Evaluation and Research, wrote in a\u00a0<a href=\"https:\/\/www.fda.gov\/media\/177068\/download\" target=\"_blank\" rel=\"noreferrer noopener\">letter to pemivibart&#8217;s manufacturer, Invivyd<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.medpagetoday.com\/infectiousdisease\/covid19\/111681?xid=nl_mpt_morningbreak2024-08-28&amp;mh=07f73d99b2b546c079b0b5a2312d87b1&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=MorningBreak_082824&amp;utm_term=NL_Gen_Int_Daily_News_Update_active\">Continue reading<\/a><\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>MedPageToday Pemivibart may have reduced activity against growing variant KP.3.1.1, agency warns. Pemivibart (Pemgarda) should only be used for pre-exposure prophylaxis of COVID-19 in immunocompromised patients when the combined national frequency of SARS-CoV-2 variants with substantially reduced susceptibility to the drug is less than or equal to 90%, the FDA announced on Monday. The agency [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[14],"tags":[],"class_list":["post-7510","post","type-post","status-publish","format-standard","hentry","category-science-and-tech"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/7510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=7510"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/7510\/revisions"}],"predecessor-version":[{"id":7511,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/7510\/revisions\/7511"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=7510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=7510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=7510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}